Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Beam Therapeutics Inc shares valued at $104,122 were sold by Bellon Christine on Apr 01 ’25. At $18.35 per share, Bellon Christine sold 5,674 shares. The insider’s holdings dropped to 117,294 shares worth approximately $1.95 million following the completion of this transaction.
Also, Evans John M. sold 30,663 shares, netting a total of over 562,684 in proceeds. Following the sale of shares at $18.35 each, the insider now holds 986,249 shares.
Before that, Ciaramella Giuseppe had sold 7,434 shares from its account. In a trade valued at $136,418, the President traded Beam Therapeutics Inc shares for $18.35 each. Upon closing the transaction, the insider’s holdings decreased to 7,434 shares, worth approximately $3.16 million.
As published in a research note from BofA Securities on March 28, 2025, Beam Therapeutics Inc [BEAM] has been rated up from a Neutral to a Buy and the price target has been revised to $42. Analysts at Scotiabank upgraded the stock from ‘”a Sector perform”‘ to ‘”a Sector outperform”‘ outlook in a report released in early March. As of January 29, 2025, Cantor Fitzgerald has increased its “Neutral” rating to a “an Overweight” for BEAM. Earlier on November 06, 2024, Leerink Partners upgraded its rating. Their new recommendation was “an Outperform” for BEAM stock which previously was a “a Market perform”.
Analyzing BEAM Stock Performance
During the last five days, there has been a surge of approximately 1.53%. Over the course of the year, Beam Therapeutics Inc shares have dropped approximately -32.98%. Shares of the company reached a 52-week high of $35.25 on 02/18/25 and a 52-week low of $13.52 on 04/07/25. A 50-day SMA is recorded $24.12, while a 200-day SMA reached $25.27.
Support And Resistance Levels for Beam Therapeutics Inc (BEAM)
According to the 24-hour chart, there is a support level at 16.11, which, if violated, would cause prices to drop to 15.61. In the upper region, resistance lies at 17.05. The next price resistance is at 17.49. RSI (Relative Strength Index) is 39.09 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.05, which suggests the price will decrease in the coming days. Percent R is at 67.23%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
